These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 32765282)
1. A 7-Years Active Pharmacovigilance Study of Adverse Drug Reactions Causing Children Admission to a Pediatric Emergency Department in Sicily. Nasso C; Mecchio A; Rottura M; Valenzise M; Menniti-Ippolito F; Cutroneo PM; Squadrito V; Squadrito F; Pallio G; Irrera N; Arcoraci V; Altavilla D Front Pharmacol; 2020; 11():1090. PubMed ID: 32765282 [TBL] [Abstract][Full Text] [Related]
2. Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study. Giardina C; Cutroneo PM; Mocciaro E; Russo GT; Mandraffino G; Basile G; Rapisarda F; Ferrara R; Spina E; Arcoraci V Front Pharmacol; 2018; 9():350. PubMed ID: 29695966 [No Abstract] [Full Text] [Related]
3. Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study. Lombardi N; Crescioli G; Bettiol A; Marconi E; Vitiello A; Bonaiuti R; Calvani AM; Masi S; Lucenteforte E; Mugelli A; Giovannelli L; Vannacci A BMC Pharmacol Toxicol; 2018 Apr; 19(1):16. PubMed ID: 29661234 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Adverse Drug Reactions in Paediatric Patients: A Retrospective Study in Turkish Hospital. Khan Z; Karataş Y; Kıroğlu O Front Pharmacol; 2021; 12():786182. PubMed ID: 34867419 [TBL] [Abstract][Full Text] [Related]
5. Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital. Mahadevappa M; Meher C; Pushpa NB; Kulkarni P; Poornima KS; Desai N Indian J Med Res; 2022 Jul; 156(1):111-121. PubMed ID: 36510903 [TBL] [Abstract][Full Text] [Related]
6. Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study. Lo Giudice I; Mocciaro E; Giardina C; Barbieri MA; Cicala G; Gioffrè-Florio M; Carpinteri G; Di Grande A; Spina E; Arcoraci V; Cutroneo PM BMC Pharmacol Toxicol; 2019 Apr; 20(1):21. PubMed ID: 31029178 [TBL] [Abstract][Full Text] [Related]
8. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study. Kurian J; Mathew J; Sowjanya K; Chaitanya KR; Ramesh M; Sebastian J; Narayanappa D Indian J Pediatr; 2016 May; 83(5):414-9. PubMed ID: 26916890 [TBL] [Abstract][Full Text] [Related]
9. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital. Geer MI; Koul PA; Tanki SA; Shah MY J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493 [TBL] [Abstract][Full Text] [Related]
10. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan. Iftikhar S; Sarwar MR; Saqib A; Sarfraz M PLoS One; 2018; 13(6):e0199456. PubMed ID: 29949616 [TBL] [Abstract][Full Text] [Related]
11. Adverse Drug Reactions Related with Antibiotic Medicines in Malawi: A Retrospective Analysis of Prevalence and Associated Factors. Chiumia FK; Chimimba F; Nyirongo HM; Kampira EL; Muula AS; Khuluza F Drug Healthc Patient Saf; 2024; 16():89-101. PubMed ID: 39070704 [TBL] [Abstract][Full Text] [Related]
12. Exploration and Evaluation of Adverse Drug Reactions Documented in a Tertiary-Care Hospital in Chennai: An In-Depth Retrospective Observational Study. Selva P; Durairajan S Cureus; 2024 May; 16(5):e60977. PubMed ID: 38915954 [TBL] [Abstract][Full Text] [Related]
13. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun. Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280 [TBL] [Abstract][Full Text] [Related]
14. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance. Blake KV; Zaccaria C; Domergue F; La Mache E; Saint-Raymond A; Hidalgo-Simon A Paediatr Drugs; 2014 Aug; 16(4):309-19. PubMed ID: 24898717 [TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence. Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831 [TBL] [Abstract][Full Text] [Related]
16. Pediatric hospital admission due to adverse drug reactions: Report from a tertiary center. Gholami K; Babaie F; Shalviri G; Javadi MR; Faghihi T J Res Pharm Pract; 2015; 4(4):212-5. PubMed ID: 26645028 [TBL] [Abstract][Full Text] [Related]
17. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department. Olivier P; Boulbés O; Tubery M; Lauque D; Montastruc JL; Lapeyre-Mestre M Drug Saf; 2002; 25(14):1035-44. PubMed ID: 12408734 [TBL] [Abstract][Full Text] [Related]
18. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533 [TBL] [Abstract][Full Text] [Related]
19. An analysis of serious adverse drug reactions at a tertiary care teaching hospital. Prajapati K; Desai M; Shah S; Panchal J; Kapadia J; Dikshit R Perspect Clin Res; 2016; 7(4):181-186. PubMed ID: 27843794 [TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions experience in a teaching hospital in Jordan. Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]